We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
-6.6%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$2.32B
AUM Growth
-$395M
(-15%)
Cap. Flow
-$169M
Cap. Flow
% of AUM
-7.28%
Top 10 Holdings %
Top 10 Hldgs %
30.51%
Holding
132
New
4
Increased
24
Reduced
70
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$15.2M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$7.74M |
| 3 |
Telefônica Brasil
VIV
|
+$3.17M |
| 4 |
Cardinal Health
CAH
|
+$2.61M |
| 5 |
ICICI Bank
IBN
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$45.5M |
| 2 |
ExxonMobil
XOM
|
+$18.5M |
| 3 |
BCE
BCE
|
+$14.1M |
| 4 |
AT&T
T
|
+$12.5M |
| 5 |
Johnson Controls International
JCI
|
+$9.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.41% |
| 2 | Financials | 14.13% |
| 3 | Technology | 9.88% |
| 4 | Energy | 9.78% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Genuine Parts
GPC
$17.9B
| $76.5M | 3.3% |
796,460
-4,890
| -0.6% | -$484K |
|
2
NextEra Energy
NEE
$184B
| $75.2M | 3.24% |
1,730,260
| – | – |
|
|
3
DuPont de Nemours
DD
$18.6B
| $74.3M | 3.2% |
548,745
+106,117
| +24% | +$15.2M |
|
4
Novartis
NVS
$302B
| $74.2M | 3.2% |
964,951
-28,463
| -3% | -$2.22M |
|
5
Merck
MRK
$322B
| $72.5M | 3.12% |
993,860
-101,583
| -9% | -$7.17M |
|
6
Welltower
WELL
$173B
| $71.4M | 3.08% |
1,028,545
-124,960
| -11% | -$8.5M |
|
7
Pfizer
PFE
$143B
| $70.9M | 3.06% |
1,711,125
-135,999
| -7% | -$5.65M |
|
8
Johnson & Johnson
JNJ
$640B
| $66.3M | 2.86% |
514,130
-40,240
| -7% | -$5.61M |
|
9
Chevron
CVX
$382B
| $63.5M | 2.74% |
584,000
+1,340
| +0.2% | +$155K |
|
10
JPMorgan Chase
JPM
$916B
| $62.8M | 2.71% |
642,930
-1,755
| -0.3% | -$187K |
|
11
Chubb
CB
$140B
| $62.4M | 2.69% |
482,941
-32,950
| -6% | -$4.26M |
|
12
Eli Lilly
LLY
$1.08T
| $61.3M | 2.64% |
529,605
| – | – |
|
13
Cisco
CSCO
$443B
| $60.6M | 2.61% |
1,399,545
+3,085
| +0.2% | +$141K |
|
|
UN
14
DELISTED
Unilever NV New York Registry Shares
UN
| $58.7M | 2.53% |
1,090,440
+17,050
| +2% | +$931K |
|
15
ConocoPhillips
COP
$144B
| $58.5M | 2.52% |
937,740
+13,960
| +2% | +$950K |
|
16
Corning
GLW
$107B
| $55.8M | 2.41% |
1,846,915
-2,680
| -0.1% | -$85.5K |
|
17
3M
MMM
$91.8B
| $55.3M | 2.38% |
347,055
| – | – |
|
18
Microsoft
MSFT
$2.9T
| $54.6M | 2.35% |
537,280
-265
| -0% | -$28.4K |
|
|
RDS.B
19
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $54.3M | 2.34% |
906,540
-4,870
| -0.5% | -$311K |
|
|
SI
20
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $53.7M | 2.31% |
957,255
+138,000
| +17% | +$7.74M |
|
|
21
AT&T
T
$164B
| $51.4M | 2.22% |
2,384,868
-535,240
| -18% | -$12.5M |
|
22
Kimberly-Clark
KMB
$37.6B
| $51.2M | 2.21% |
449,415
| – | – |
|
23
Travelers Companies
TRV
$81.1B
| $50.6M | 2.18% |
422,935
-2,460
| -0.6% | -$308K |
|
24
Wells Fargo
WFC
$254B
| $49.3M | 2.13% |
1,070,075
-110,810
| -9% | -$5.68M |
|
|
RTN
25
DELISTED
Raytheon Company
RTN
| $49.3M | 2.13% |
321,475
| – | – |
|
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Cullen Capital Management held 132 positions worth $2.32B, down 15% from $2.71B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Cullen Capital Management withdrew a net $169M in Q4 2018, closing 4 positions and reducing 70 holdings. Its most notable exit was Novo Nordisk, an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, Cullen Capital Management opened a new position in Cardinal Health worth $2.23M.
- Cullen Capital Management's largest Q4 2018 buy was Cardinal Health: 50,030 shares worth $2.23M.
- Cullen Capital Management added most to DuPont de Nemours in Q4 2018, an estimated $15.2M increase.
- Cullen Capital Management's biggest Q4 2018 reduction was MetLife, cutting an estimated $45.5M.
- Cullen Capital Management fully exited Novo Nordisk in Q4 2018, selling an estimated $2.81M.
- Cullen Capital Management's ten largest holdings make up 31% of its $2.32B portfolio in Q4 2018.
- Cullen Capital Management opened 4 new positions and closed 4 in Q4 2018.
- Cullen Capital Management's portfolio value fell 15% quarter-over-quarter to $2.32B.
Based on Cullen Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.